Patents 29show all

  • 22
    C07D - Heterocyclic compounds
  • 15
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
  • 7
    A61K - Preparations for medical, dental, or toilet purposes
  • 6
    C40B - Combinatorial chemistry
  • 2
    C07K - Peptides
  • 2
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 1
    C12N - Microorganisms or enzymes
  • 1
    C12Y - Enzymes

SEC Filings show all


13
D

Contact Information

SEC Form D Funding Events

DateOfferedSoldType
2014-10-23$4,000,000$4,000,000Debt
2014-05-12$1,000,000$1,000,000Debt
2012-07-03$11,999,997$5,495,237Equity
2012-02-03$441,008$50,000Debt
2011-12-15$750,000$216,658Debt
2011-05-16$2,999,975$2,999,975Equity
2011-01-06$8,468,000$7,104,000Equity, Debt, Option to Acquire

Key Executives

  • Derek Small
    Executive Officer, Director
  • James Schulz
    Executive Officer
  • Kapil Dhingra
    Director
  • Michael Gargano
    Director
  • Alan Lewis
    Director
  • Viren Mehta
    Director
  • Mark Simon
    Director
  • Colin Goddard
    Executive Officer, Director
  • Geoff Smith
    Director
  • Douglas Reed
    Director